NM HB 10: PHYSICIAN ASSISTANT INTERSTATE COMPACT
New Mexico HB 10 proposes the Physician Assistant Interstate Compact, enabling PAs to practice across state lines. This reduces licensing barriers for telehealth platforms and e-prescribers, but requires adherence to compact rules and state-specific controlled substance prescribing laws.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 15, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers operating in or serving New Mexico should confirm how it applies to their specific situation before acting. There is a time constraint attached: Bill is active in 2024 session; monitor for passage and effective date.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New Mexico is considering joining the PA Interstate Compact, which would allow PAs licensed in other compact states to practice in NM without additional licensure, subject to compact requirements.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers operating in or serving New Mexico
What you must do
Monitor bill progress; if enacted, ensure PAs register with the compact and comply with NM's scope of practice and controlled substance prescribing rules.
Deadline
Bill is active in 2024 session; monitor for passage and effective date.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- ID H0497: Uniform controlled substances
- GLP‑1 Compliance- FDA Targets Telehealth Marketing in 30 New Warning Letters - The National Law Review
- David Enright, M.D.; Decision and Order
- Shane Lydon, M.D.; Decision and Order
- DEA proposes long-awaited rule for telehealth controlled substance prescriptions - Healthcare Dive